J Frontier Co., Ltd. (JP:2934)

:2934

2934

J Frontier Co., Ltd.

RESEARCH TOOLSreports

J Frontier Co., Ltd. (2934) Price & Analysis

0 Followers

2934 Stock Chart & Stats

¥1326.00

¥89.00(6.94%)

At close: Jan 08 4:00 PM EST

¥1326.00

¥89.00(6.94%)

Day’s Range― - ―

52-Week Range¥1,196.00 - ¥2,110.00

Previous CloseN/A

Volume44.20K

Average Volume (3M)40.58K

Market Cap

¥7.15B

Enterprise Value¥10.10B

Total Cash (Recent Filing)¥2.17B

Total Debt (Recent Filing)¥4.34B

Price to Earnings (P/E)―

Beta1.00

Next Earnings

Apr 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-29.46

Shares Outstanding5,333,465

10 Day Avg. Volume58,880

30 Day Avg. Volume40,583

Financial Highlights & Ratios

PEG Ratio-0.89

Price to Book (P/B)5.74

Price to Sales (P/S)0.38

P/FCF Ratio18.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improving Free Cash FlowImproving free cash flow growth indicates the company is generating more discretionary cash, enhancing its ability to fund operations, invest in product and service development, and service debt. This supports medium-term solvency and strategic flexibility despite revenue volatility.

Stable Gross Profit MarginA relatively stable gross margin suggests the company maintains pricing power or cost control in core products/services. Stable gross margins provide a durable base for operating profit recovery if SG&A and operating efficiency improve, supporting longer-term margin sustainability.

Healthcare Information Sector ExposureOperating in medical and healthcare information services positions the company in a structurally steady sector with ongoing demand for data, software and services. This industry exposure supports recurring revenue potential and resilience to cyclical downturns over the medium term.

Bears Say

High LeverageA high debt-to-equity ratio constrains financial flexibility, increases interest burden and raises refinancing risk. Over 2-6 months, leverage limits the firm’s ability to invest in growth or absorb shocks, making operational recovery and strategic initiatives more difficult until debt is reduced.

Inconsistent Revenue GrowthInconsistent top-line trends and periodic declines signal weak demand stability or execution issues. This volatility complicates planning, limits sustainable margin expansion, and makes free cash flow and profitability projections less reliable for medium-term strategic decisions.

Weak Operating Cash ConversionNegative operating cash conversion means reported earnings are not translating into cash, straining working capital and increasing dependence on financing. Over the medium term this can hamper reinvestment, debt reduction and operational resilience unless conversion improves.

2934 FAQ

What was J Frontier Co., Ltd.’s price range in the past 12 months?

J Frontier Co., Ltd. lowest stock price was ¥1196.00 and its highest was ¥2110.00 in the past 12 months.

What is J Frontier Co., Ltd.’s market cap?

J Frontier Co., Ltd.’s market cap is ¥7.15B.

When is J Frontier Co., Ltd.’s upcoming earnings report date?

J Frontier Co., Ltd.’s upcoming earnings report date is Apr 14, 2026 which is in 11 days.

How were J Frontier Co., Ltd.’s earnings last quarter?

J Frontier Co., Ltd. released its earnings results on Jan 14, 2026. The company reported -¥29.46 earnings per share for the quarter, missing the consensus estimate of N/A by -¥29.46.

Is J Frontier Co., Ltd. overvalued?

According to Wall Street analysts J Frontier Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does J Frontier Co., Ltd. pay dividends?

J Frontier Co., Ltd. does not currently pay dividends.

What is J Frontier Co., Ltd.’s EPS estimate?

J Frontier Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does J Frontier Co., Ltd. have?

J Frontier Co., Ltd. has 5,333,465 shares outstanding.

What happened to J Frontier Co., Ltd.’s price movement after its last earnings report?

J Frontier Co., Ltd. reported an EPS of -¥29.46 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.961%.

Which hedge fund is a major shareholder of J Frontier Co., Ltd.?

Currently, no hedge funds are holding shares in JP:2934

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

J Frontier Co., Ltd.

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.